Form 4 for LLY Lilly (Eli)
Accepted 2024-03-11 00:00:00 ET · period of report 2024-02-12 · accession 0000059478-24-000082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-11 | 2024-03-11 | LLY | Zakrowski Donald A | SVP, CAO, Fin | S - Sale | $753.60 | -750 | 7,880 | -9% | -$565.2K |
| DM | 2024-03-11 | 2024-02-12 | LLY | Zakrowski Donald A | SVP, CAO, Fin | A - Grant | $0.00 | +370 | 184 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-11 | S | D | 750 | $753.60 | 7,880 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2024-02-12 | A | A | 186 | $0.00 | 186 | D | — · 2027-02-16 to 2027-02-16 | 186 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. These grants were inadvertently omitted from the reporting person's Form 4 filed on February 14, 2024. |
| 3 | Derivative | Restricted Stock Unit | 2024-02-12 | A | A | 184 | $0.00 | 184 | D | — · 2026-02-16 to 2026-02-16 | 184 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. These grants were inadvertently omitted from the reporting person's Form 4 filed on February 14, 2024. |